Tuesday, May 21, 2019 11:01:40 AM
I'm here for one primary reason:
This is an investment process for me, nothing more.
Of course I deeply appreciate the opportunity to participate in the humanitarian aspects of this vehicle investment as I'm sure touches most everyone here. Still, I don't believe any one of us would be here were it not for the opportunity to make money.
This morning I sold a couple of poorly performing stocks to provide the cash with which to add a few hundred AVMXY so as to round out my aggregated positioning to an even 53,000 shares while simultaneously containing my margin commitment within self-imposed boundaries.
I paid the ask---$6.82, no silly quibbling over a penny or two I might be paying needlessly. I just wanted to get the job done, no ego junk.
This is my second largest investment in the stock market. My ranch is the most important investment followed by NGL. I am responsible for these investments.
I am not responsible for what happens with my dollars once they are used to buy positions! I don't get into pretending that making money is a direct result of how the companies handle their leadership responsibilities because of me! I'm just a long-forgotten cuticle along for the ride.
That said, I do contribute to certain charities and do so regularly. I'm not contributing to children unfortunately burned nor am I a contributor to factories manufacturing ReCell kits for eventual commercial sales. Causes do crop up from time to time and I indulge in doing my best to be of help. But the bottom line here is that I'm here to make money. It sounds cold, maybe, but it's the truth.
My sense is that much of the ongoing debates over this and that which tdeck finds unpleasant is really not much more than the manifestation of investor-related fears. Hand-holding can be an effective coping tool but I'll urge people here to consider there might be additional ways of dealing with self-doubts and threats.
Threats from the outside are very often manifestations of unsettled controversy from within.
My thoughts for whatever they may be worth.
Recent RCEL News
- AVITA Medical to Announce First Quarter 2024 Financial Results • GlobeNewswire Inc. • 04/15/2024 09:05:00 PM
- AVITA Medical Updates Expected First Quarter 2024 Revenue • GlobeNewswire Inc. • 04/10/2024 09:11:25 PM
- AVITA Medical Submits Response to FDA, Resuming Review Clock for RECELL GO PMA Supplement • GlobeNewswire Inc. • 02/29/2024 09:02:00 PM
- AVITA Medical to Present at TD Cowen 44th Annual Health Care Conference • GlobeNewswire Inc. • 02/29/2024 02:00:00 PM
- AVITA Medical to Host Investor Webinar Briefing • GlobeNewswire Inc. • 02/23/2024 02:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 09:02:06 PM
- AVITA Medical Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance • GlobeNewswire Inc. • 02/22/2024 09:01:00 PM
- AVITA Medical to Announce Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 02/01/2024 09:10:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 09:05:12 PM
- AVITA Medical Announces Exclusive Distribution Agreement with Stedical Scientific • GlobeNewswire Inc. • 01/10/2024 09:01:00 PM
- AVITA Medical Announces Preliminary 2023 Financial Highlights, Provides 2024 Financial Guidance and Business Update • GlobeNewswire Inc. • 01/10/2024 02:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 10:51:10 PM
- AVITA Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/04/2024 02:00:00 PM
- AVITA Medical to Host Investor Webinar Briefing • GlobeNewswire Inc. • 12/04/2023 02:00:00 PM
- AVITA Medical to Present at the Piper Sandler 35th Annual Healthcare Conference • GlobeNewswire Inc. • 11/21/2023 09:15:00 PM
- Keep An Eye Out: Pre-Market Movers And Analyst Recommendations • IH Market News • 11/21/2023 02:10:28 PM
- AVITA Medical Updates Full Year 2023 Guidance • GlobeNewswire Inc. • 11/20/2023 09:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 09:09:50 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:07:10 PM
- AVITA Medical Reports Third Quarter Financial Results with 51% Revenue Growth over the Same Period the Prior Year • GlobeNewswire Inc. • 11/09/2023 09:01:00 PM
- AVITA Medical Announces Distribution Partnership with PolyMedics Innovations to Expand to Europe • GlobeNewswire Inc. • 11/09/2023 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/23/2023 08:36:53 PM
- AVITA Medical to Announce Third Quarter 2023 Financial Results • GlobeNewswire Inc. • 10/19/2023 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/18/2023 01:07:51 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM